Regencell Bioscience Holdings Limited Ordinary Shares
Symbol: RGC (NASDAQ)
13.37
▲ (0.41%) 0.055
Company Description:
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
Key Stats
- Today's Open: $13.365
- Today's High: $13.365
- Today's Low: $13.365
- Today's Volume: 202
- Yesterday Close: $13.31
- Yesterday High: $13.57
- Yesterday Low: $13.2687
- Yesterday Volume: 310.31K
- Last Min Volume: 200
- Last Min High: $13.365
- Last Min Low: $13.365
- Last Min VWAP: $13.365
Company Profile
- Name: Regencell Bioscience Holdings Limited Ordinary Shares
- Website: https://www.regencellbioscience.com
- Listed Date: 2021-07-16
- Location: ,
- Market Status: Active
- CIK Number: 0001829667
- SIC Code:
- SIC description:
- Market Cap: $6.58B
- Round Lot: 100
- Outstanding Shares: 494.49M
- Asset Type: CS
RECENT FILINGS FOR RGC
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-07-11 | SCHEDULE 13D/A | View |
| 2025-06-30 | 6-K | View |
| 2025-06-30 | 6-K | View |
| 2025-06-17 | 6-K | View |
| 2025-06-02 | 6-K | View |
| 2025-03-13 | SCHEDULE 13D/A | View |
| 2025-01-15 | 6-K | View |
| 2024-10-25 | 20-F | View |
| 2024-06-20 | 6-K | View |
| 2024-01-02 | 6-K | View |
| 2023-12-15 | 6-K | View |
| 2023-10-27 | 20-F | View |
| 2023-06-15 | 6-K | View |
| 2023-06-05 | 6-K | View |
| 2023-03-17 | 6-K | View |
| 2023-02-28 | 6-K | View |
| 2023-01-04 | 6-K | View |
| 2022-12-22 | 6-K | View |
| 2022-10-31 | 20-F | View |
| 2022-09-12 | 6-K | View |
Latest News on RGC